Výsledky vyhledávání - "Giovana Garziera"

Akademický článek

Incidence of tuberculosis infection in spondyloarthritis patients treated with biological and conventional disease-modifying anti-rheumatic drugs in an endemic area

Autor: André Luis Bittencourt Morsch, Lílian Rodrigues Henrique, Denise Rossato Silva, Giovana Garziera, Ricardo Machado Xavier, Vanessa Hax, Manoela Fantinel Ferreira, Charles Lubianca Kohem, Aline Castello Branco Mancuso, Andrese Aline Gasparin, Claiton Viegas Brenol, Nicole Pamplona Bueno de Andrade, Franciele de Almeida Menegat Lic, Daniela Viecceli, Renata Bohn, Penélope Esther Palominos

Publikováno v: Clinical and Biomedical Research, Vol 40, Iss 1 (2020)

Antecedentes : Os registros de acompanhamento de pacientes com espondiloartrite (SpA) forneceram evidências de que os inibidores do fator de necrose tumoral (TNFi) aumentam a incidência de infecção tuberculosa ativa (TB). No entanto, a maioria de

Externí odkaz: https://doaj.org/article/522e0063247641d5a9d856a5e8fed700

Zobrazit plný text záznamu

Incidence of tuberculosis infection in spondyloarthritis patients treated with biological and conventional disease-modifying anti-rheumatic drugs in an endemic area

Autor: Franciele de Almeida Menegat, André Luis Bittencourt Morsch, Denise Rossato Silva, Claiton Viegas Brenol, Aline Castello Branco Mancuso, Renata Bohn, Lilian Rodrigues Henrique, Ricardo Machado Xavier, Giovana Garziera, Nicole Pamplona Bueno de Andrade, Vanessa Hax, Daniela Viecceli, M. A. J. F. Ferreira, Charles Lubianca Kohem, Penelope Esther Palominos, Andrese Aline Gasparin

Publikováno v: Clinical & Biomedical Research; Vol. 40 No. 1 (2020)
Clinical and Biomedical Research; v. 40 n. 1 (2020)
Clinical and Biomedical Research
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Clinical and Biomedical Research, Vol 40, Iss 1 (2020)
Repositório Institucional da UFRGS

Antecedentes : Os registros de acompanhamento de pacientes com espondiloartrite (SpA) forneceram evidencias de que os inibidores do fator de necrose tumoral (TNFi) aumentam a incidencia de infeccao tuberculosa ativa (TB). No entanto, a maioria desses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447e2ad0026557d2c0a5cda3a723ea9b
https://seer.ufrgs.br/index.php/hcpa/article/view/98397

Zobrazit plný text záznamu

Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents

Autor: André Luis Bittencourt Morsch, Giovana Garziera, Denise Rossato Silva, Penelope Esther Palominos, Claiton Viegas Brenol, Fernanda Luiza Staub, Felipe Otesbelgue

Publikováno v: Clinical Rheumatology. 36:1891-1896

The introduction of biological agents, especially the tumor necrosis factor inhibitors (anti-TNF), for the treatment of rheumatic diseases increased the risk of developing tuberculosis (TB). Screening for latent TB infection (LTBI) is strongly recomm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3935faebb3eb9074763bbcb1105bfd9d
https://doi.org/10.1007/s10067-017-3714-6

Zobrazit plný text záznamu

FRI0181 Twelve years follow-up of patients with spondyloarthritis in an endemic city demonstrates high risk of active tuberculosis infection

Autor: André Luis Bittencourt Morsch, N. T. de Andrade, Charles Lubianca Kohem, Franciele de Almeida Menegat, Claiton Viegas Brenol, M. A. J. F. Ferreira, P. Palominos, Renata Bohn, Giovana Garziera, Daniela Viecceli, Andrese Aline Gasparin, Ricardo Machado Xavier, Diana Perin da Silva

Publikováno v: FRIDAY, 15 JUNE 2018.

Background Anti-tumour necrosis factor (anti-TNF) agents can induce progression from latent tuberculosis infection (LTBI) to active tuberculosis (TB) in patient with rheumatic diseases1,2. In a high tuberculosis incidence setting, TB cases developed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::91944aa6a82e735fa5e2f91db4fa7f6f
https://doi.org/10.1136/annrheumdis-2018-eular.4485

Zobrazit plný text záznamu

AB1117 Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases under treatment with anti-tumor necrosis factor drugs

Autor: Fernanda Luiza Staub, Silva, F Otesbelgue, P. Palominos, Alb Morsch, Claiton Viegas Brenol, Giovana Garziera

Publikováno v: Abstracts Accepted for Publication.

Background The introduction of biological agents, especially the tumor necrosis factor inhibitors (anti-TNF) for the treatment of rheumatic diseases increased the risk of developing tuberculosis (TB). Screening for latent TB infection (LTBI) is stron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1bb57d3af9d72270873ece9fdacbc64
https://doi.org/10.1136/annrheumdis-2017-eular.6340

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání